Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 精华制药集团股份有限公司是一家主要从事中成药、原料药及医药中间体和西药制剂的研发、生产和销售的企业.目前公司共拥有248个规格的药品批准文号,涵盖片剂、胶囊剂、丸剂、颗粒剂、注射剂、散剂、糖浆剂等七大类型;其中57个规格药品被国家药监局列入OTC目录,包括甲类目录26个、乙类目录31个;138个规格药品被国家劳动和社会保障部列入医保目录,包括甲类目录91个、乙类目录47个.公司产品中,王氏保赤丸和季德胜蛇药片为国家中药保密品种,王氏保赤丸、金荞麦片、固本咳喘片三个中成药品种被列为国家二级中药保护品种,其中王氏保赤丸、季德胜蛇药片为公司独家生产;化学原料药主要包括苯巴比妥、保泰松、氟尿嘧啶等产品,其中苯巴比妥为公司独家批量生产.公司"南通"、"季德胜"商标被评为江苏省著名商标,"宁宁"商标被评为南通市知名商标;"南通"王氏保赤丸、"季德胜"蛇药片2006年获江苏名牌产品证书,"宁宁"正柴胡饮颗粒2005年获得江苏名牌产品证书,"苏通"氟尿嘧啶、苯巴比妥获南通名牌产品证书.公司已拥有3项发明专利,另有11项发明专利申请已获受理.公司原料药已获得9项国际认证,其中氟尿嘧啶通过了美国FDA认证,苯巴比妥、保泰松等四个产品获得了欧洲COS认证。
Main Business 传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、生物制药等的研发、生产和销售。
Legal Representative 尹红宇
Top Executives
董事长：尹红宇
副董事长：吴玉祥
董事：张剑桥,吴玉祥,成剑
独立董事：张晓梅,刘静,王煦
Top 5 Shareholder
Shareholder name Nature Holding Date
南通产业控股集团有限公司流通A股34.39%31/03/2024
江苏南通港闸经济开发区城市建设发展有限公司流通A股3.56%31/03/2024
昝圣达流通A股0.61%31/03/2024
香港中央结算有限公司流通A股0.46%31/03/2024
周云中限售股+流通A股0.36%31/03/2024
Company Secretary 王剑锋
Solicitors 江苏世纪同仁律师事务所
Auditors 天衡会计师事务所（特殊普通合伙）
Tel No 0513-85609123;0513-85609158
Fax No 0513-85609115
Website www.ntjhzy.com
Email ntjh@jhoa.net;fyq@jhoa.net;it@jhoa.net
Company Address
Register: 江苏省南通市港闸经济开发区兴泰路9号
Office: 江苏省南通市崇川区青年中路198号国城生活广场办公楼A幢20、21、22、23、24、25层
Listing Date 03/02/2010
Shares Capital
Shares Capital: 814,180,908
Total A Share: 814,180,908
Listed A Share: 812,006,309
Non-tradable A Share: 2,174,599
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.304
DPS(RMB)* ¥ 0.092
NBV Per Share(RMB)* ¥ 3.003
Market Capitalization(RMB) 6.025B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.